Lennham Pharmaceuticals

About:

Lennham Pharmaceuticals helps to improve the metabolic and pharmacological profiles of drugs through deuterium chemistry.

Website: https://www.lennham.com/

Description:

Lennham Pharmaceuticals is a pharmaceutical company that helps to improve the metabolic and pharmacological profiles of drugs through deuterium chemistry. It focuses on the application of deuterium chemistry to well-characterized compounds that have enabled it to develop a pipeline of products such as deuterium-enriched forms of psilocybin, and caffeine.

Total Funding Amount:

$3.53M

Headquarters Location:

Concord, Massachusetts, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)lennham.com

Founders:

BRADFORD SIPPY

Number of Employees:

101-250

Last Funding Date:

2023-04-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai